Skip to main content
. 2021 Jun 15;12:694344. doi: 10.3389/fimmu.2021.694344

Figure 1.

Figure 1

CBLEB reduces cyclophosphamide-induced death, weight loss, immune dysfunction, and organ damage. (A) Weight plot (*P < 0.05; **P < 0.01; ***P < 0.001 versus the CTX group), (B) thymus and spleen indexes, (C) mean corpuscular hemoglobin and red cell distribution width in the serum samples, (D) concentrations of total protein, albumin, GGT, creatinine, blood urea, M-CSF, and MIP-3α in the serum samples; (E) representative images of the spleen, colon, liver, and lung samples stained by H&E and the corresponding histological scores in the CTX (n = 6), CTX+CBLEB (n = 9), and HC (n = 9) groups. *P < 0.05; **P < 0.01; ***P < 0.001; ## P adj < 0.01.